The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells

Alessandra Rossi, Giuseppe Russo, Andrew Puca, Raffaele La Montagna, Mariella Caputo, Eliseo Mattioli, Massimo Lopez, Antonio Giordano, Francesca Pentimalli

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Abacavir is one of the most efficacious nucleoside analogues, with a well-characterized inhibitory activity on reverse transcriptase enzymes of retroviral origin, and has been clinically approved for the treatment of AIDS. Recently, Abacavir has been shown to inhibit also the human telomerase activity. Telomerase activity seems to be required in essentially all tumours for the immortalization of a subset of cells, including cancer stem cells. In fact, many cancer cells are dependent on telomerase for their continued replication and therefore telomerase is an attractive target for cancer therapy. Telomerase expression is upregulated in primary primitive neuroectodermal tumours and in the majority of medulloblastomas suggesting that its activation is associated with the development of these diseases. Therefore, we decided to test Abacavir activity on human medulloblastoma cell lines with high telomerase activity. We report that exposure to Abacavir induces a dose-dependent decrease in the proliferation rate of medulloblastoma cells. This is associated with a cell accumulation in the G2/M phase of the cell cycle in the Daoy cell line, and with increased cell death in the D283-MED cell line, and is likely to be dependent on the inhibition of telomerase activity. Interestingly, both cell lines showed features of senescence after Abacavir treatment. Moreover, after Abacavir exposure we detected, by immunofluorescence staining, increased protein expression of the glial marker glial fibrillary acidic protein and the neuronal marker synaptophysin in both medulloblastoma cell lines. In conclusion, our results suggest that Abacavir reduces proliferation and induces differentiation of human medulloblastoma cells through the downregulation of telomerase activity. Thus, using Abacavir, alone or in combination with current therapies, might be an effective therapeutic strategy for the treatment of medulloblastoma.

Original languageEnglish
Pages (from-to)235-243
Number of pages9
JournalInternational Journal of Cancer
Volume125
Issue number1
DOIs
Publication statusPublished - Jul 1 2009

Fingerprint

Medulloblastoma
Telomerase
Nucleosides
Growth
Cell Line
Human Activities
Therapeutics
Primitive Neuroectodermal Tumors
Neoplasms
Synaptophysin
Neoplastic Stem Cells
abacavir
G2 Phase
RNA-Directed DNA Polymerase
Glial Fibrillary Acidic Protein
Neuroglia
Cell Division
Fluorescent Antibody Technique
Cell Cycle
Acquired Immunodeficiency Syndrome

Keywords

  • Abacavir
  • Differentiation
  • Medulloblastoma
  • Reverse transcriptase
  • Senescence
  • Telomerase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. / Rossi, Alessandra; Russo, Giuseppe; Puca, Andrew; La Montagna, Raffaele; Caputo, Mariella; Mattioli, Eliseo; Lopez, Massimo; Giordano, Antonio; Pentimalli, Francesca.

In: International Journal of Cancer, Vol. 125, No. 1, 01.07.2009, p. 235-243.

Research output: Contribution to journalArticle

Rossi, A, Russo, G, Puca, A, La Montagna, R, Caputo, M, Mattioli, E, Lopez, M, Giordano, A & Pentimalli, F 2009, 'The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells', International Journal of Cancer, vol. 125, no. 1, pp. 235-243. https://doi.org/10.1002/ijc.24331
Rossi, Alessandra ; Russo, Giuseppe ; Puca, Andrew ; La Montagna, Raffaele ; Caputo, Mariella ; Mattioli, Eliseo ; Lopez, Massimo ; Giordano, Antonio ; Pentimalli, Francesca. / The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. In: International Journal of Cancer. 2009 ; Vol. 125, No. 1. pp. 235-243.
@article{d5572219bdac42628c868ea9d2c9f428,
title = "The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells",
abstract = "Abacavir is one of the most efficacious nucleoside analogues, with a well-characterized inhibitory activity on reverse transcriptase enzymes of retroviral origin, and has been clinically approved for the treatment of AIDS. Recently, Abacavir has been shown to inhibit also the human telomerase activity. Telomerase activity seems to be required in essentially all tumours for the immortalization of a subset of cells, including cancer stem cells. In fact, many cancer cells are dependent on telomerase for their continued replication and therefore telomerase is an attractive target for cancer therapy. Telomerase expression is upregulated in primary primitive neuroectodermal tumours and in the majority of medulloblastomas suggesting that its activation is associated with the development of these diseases. Therefore, we decided to test Abacavir activity on human medulloblastoma cell lines with high telomerase activity. We report that exposure to Abacavir induces a dose-dependent decrease in the proliferation rate of medulloblastoma cells. This is associated with a cell accumulation in the G2/M phase of the cell cycle in the Daoy cell line, and with increased cell death in the D283-MED cell line, and is likely to be dependent on the inhibition of telomerase activity. Interestingly, both cell lines showed features of senescence after Abacavir treatment. Moreover, after Abacavir exposure we detected, by immunofluorescence staining, increased protein expression of the glial marker glial fibrillary acidic protein and the neuronal marker synaptophysin in both medulloblastoma cell lines. In conclusion, our results suggest that Abacavir reduces proliferation and induces differentiation of human medulloblastoma cells through the downregulation of telomerase activity. Thus, using Abacavir, alone or in combination with current therapies, might be an effective therapeutic strategy for the treatment of medulloblastoma.",
keywords = "Abacavir, Differentiation, Medulloblastoma, Reverse transcriptase, Senescence, Telomerase",
author = "Alessandra Rossi and Giuseppe Russo and Andrew Puca and {La Montagna}, Raffaele and Mariella Caputo and Eliseo Mattioli and Massimo Lopez and Antonio Giordano and Francesca Pentimalli",
year = "2009",
month = "7",
day = "1",
doi = "10.1002/ijc.24331",
language = "English",
volume = "125",
pages = "235--243",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells

AU - Rossi, Alessandra

AU - Russo, Giuseppe

AU - Puca, Andrew

AU - La Montagna, Raffaele

AU - Caputo, Mariella

AU - Mattioli, Eliseo

AU - Lopez, Massimo

AU - Giordano, Antonio

AU - Pentimalli, Francesca

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Abacavir is one of the most efficacious nucleoside analogues, with a well-characterized inhibitory activity on reverse transcriptase enzymes of retroviral origin, and has been clinically approved for the treatment of AIDS. Recently, Abacavir has been shown to inhibit also the human telomerase activity. Telomerase activity seems to be required in essentially all tumours for the immortalization of a subset of cells, including cancer stem cells. In fact, many cancer cells are dependent on telomerase for their continued replication and therefore telomerase is an attractive target for cancer therapy. Telomerase expression is upregulated in primary primitive neuroectodermal tumours and in the majority of medulloblastomas suggesting that its activation is associated with the development of these diseases. Therefore, we decided to test Abacavir activity on human medulloblastoma cell lines with high telomerase activity. We report that exposure to Abacavir induces a dose-dependent decrease in the proliferation rate of medulloblastoma cells. This is associated with a cell accumulation in the G2/M phase of the cell cycle in the Daoy cell line, and with increased cell death in the D283-MED cell line, and is likely to be dependent on the inhibition of telomerase activity. Interestingly, both cell lines showed features of senescence after Abacavir treatment. Moreover, after Abacavir exposure we detected, by immunofluorescence staining, increased protein expression of the glial marker glial fibrillary acidic protein and the neuronal marker synaptophysin in both medulloblastoma cell lines. In conclusion, our results suggest that Abacavir reduces proliferation and induces differentiation of human medulloblastoma cells through the downregulation of telomerase activity. Thus, using Abacavir, alone or in combination with current therapies, might be an effective therapeutic strategy for the treatment of medulloblastoma.

AB - Abacavir is one of the most efficacious nucleoside analogues, with a well-characterized inhibitory activity on reverse transcriptase enzymes of retroviral origin, and has been clinically approved for the treatment of AIDS. Recently, Abacavir has been shown to inhibit also the human telomerase activity. Telomerase activity seems to be required in essentially all tumours for the immortalization of a subset of cells, including cancer stem cells. In fact, many cancer cells are dependent on telomerase for their continued replication and therefore telomerase is an attractive target for cancer therapy. Telomerase expression is upregulated in primary primitive neuroectodermal tumours and in the majority of medulloblastomas suggesting that its activation is associated with the development of these diseases. Therefore, we decided to test Abacavir activity on human medulloblastoma cell lines with high telomerase activity. We report that exposure to Abacavir induces a dose-dependent decrease in the proliferation rate of medulloblastoma cells. This is associated with a cell accumulation in the G2/M phase of the cell cycle in the Daoy cell line, and with increased cell death in the D283-MED cell line, and is likely to be dependent on the inhibition of telomerase activity. Interestingly, both cell lines showed features of senescence after Abacavir treatment. Moreover, after Abacavir exposure we detected, by immunofluorescence staining, increased protein expression of the glial marker glial fibrillary acidic protein and the neuronal marker synaptophysin in both medulloblastoma cell lines. In conclusion, our results suggest that Abacavir reduces proliferation and induces differentiation of human medulloblastoma cells through the downregulation of telomerase activity. Thus, using Abacavir, alone or in combination with current therapies, might be an effective therapeutic strategy for the treatment of medulloblastoma.

KW - Abacavir

KW - Differentiation

KW - Medulloblastoma

KW - Reverse transcriptase

KW - Senescence

KW - Telomerase

UR - http://www.scopus.com/inward/record.url?scp=66149128066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149128066&partnerID=8YFLogxK

U2 - 10.1002/ijc.24331

DO - 10.1002/ijc.24331

M3 - Article

C2 - 19358275

AN - SCOPUS:66149128066

VL - 125

SP - 235

EP - 243

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -